Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT02512978

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02512978
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02512978. Randomized; no masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2018-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
Condition
Hypothyroidism
Intervention (Drug)
Levothyroxine
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
Beijing Municipal Science & Technology Commission (class: other)
Collaborator
Peking Union Medical College Hospital (class: other)
Collaborator
Peking University Third Hospital (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
Beijing Chao Yang Hospital (class: other)
Collaborator
Beijing Friendship Hospital (class: other)
Collaborator
The Luhe Teaching Hospital of the Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct02512978
Content hash
ffe427f4a084353992a2cfc9b1b0789c6917d1cc6d49f13975e32981d10b7f27